Citigroup Inc Amicus Therapeutics, Inc. Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 112,259 shares of FOLD stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112,259

Previous 356,275 68.49%

Holding current value

$1.05 Million

Previous $2.04 Million 56.69%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$5.84 - $8.57 $1.43 Million - $2.09 Million	-244,016 Reduced 68.49%	112,259 $884,000
Q2 2025 Aug 11, 2025	SELL	$5.64 - $8.0 $508,524 - $721,312	-90,164 Reduced 20.2%	356,275 $2.04 Million
Q1 2025 May 12, 2025	SELL	$8.16 - $9.85 $945,695 - $1.14 Million	-115,894 Reduced 20.61%	446,439 $3.64 Million
Q4 2024 Feb 12, 2025	BUY	$9.36 - $12.01 $2.24 Million - $2.88 Million	239,493 Added 74.18%	562,333 $5.3 Million
Q3 2024 Nov 12, 2024	BUY	$9.55 - $12.09 $1.69 Million - $2.13 Million	176,496 Added 120.6%	322,840 $3.45 Million
Q2 2024 Aug 12, 2024	SELL	$9.04 - $11.75 $5.3 Million - $6.89 Million	-586,792 Reduced 80.04%	146,344 $1.45 Million
Q1 2024 May 10, 2024	BUY	$11.43 - $14.24 $2.99 Million - $3.73 Million	261,818 Added 55.55%	733,136 $8.64 Million
Q4 2023 Feb 09, 2024	BUY	$9.97 - $14.52 $963,610 - $1.4 Million	96,651 Added 25.8%	471,318 $6.69 Million
Q3 2023 Nov 09, 2023	BUY	$11.78 - $13.86 $121,369 - $142,799	10,303 Added 2.83%	374,667 $4.56 Million
Q2 2023 Aug 10, 2023	SELL	$10.72 - $13.3 $2.48 Million - $3.08 Million	-231,279 Reduced 38.83%	364,364 $4.58 Million
Q1 2023 May 11, 2023	BUY	$10.91 - $13.54 $2.39 Million - $2.97 Million	219,224 Added 58.24%	595,643 $6.61 Million
Q4 2022 Feb 09, 2023	SELL	$9.89 - $12.7 $2.41 Million - $3.09 Million	-243,325 Reduced 39.26%	376,419 $4.6 Million
Q3 2022 Nov 10, 2022	BUY	$9.82 - $12.75 $314,691 - $408,586	32,046 Added 5.45%	619,744 $6.47 Million
Q2 2022 Aug 10, 2022	BUY	$6.23 - $11.12 $2.22 Million - $3.96 Million	355,935 Added 153.58%	587,698 $6.31 Million
Q1 2022 May 12, 2022	SELL	$7.89 - $12.48 $2.19 Million - $3.46 Million	-277,523 Reduced 54.49%	231,763 $2.19 Million
Q4 2021 Feb 10, 2022	BUY	$9.82 - $12.44 $1.92 Million - $2.43 Million	195,405 Added 62.25%	509,286 $5.88 Million
Q3 2021 Nov 10, 2021	BUY	$8.74 - $11.84 $2.74 Million - $3.72 Million	313,881 New	313,881 $3 Million

Others Institutions Holding FOLD

# of Institutions

307

Shares Held

329M

Call Options Held

364K

Put Options Held

249K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.61B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account